CTACK, human recombinant protein
ALP, CTACK, ESKINE, ILC, PESKY, SCYA27, CCL27, C-C motif chemokine 27, Small-inducible cytokine A27,
|Calculated MW||10.3 kDa|
|Other Names||ALP, CTACK, ESKINE, ILC, PESKY, SCYA27, CCL27, C-C motif chemokine 27, Small-inducible cytokine A27, IL-11 R-alpha-locus chemokine, Skinkine, ESkine, Cutaneous T-cell-attracting chemokine.|
|Sequence||MFLLPPSTAC CTQLYRKPLS DKLLRKVIQV ELQEADGDCH LQAFVLHLAQ RSICIHPQNP SLSQWFEHQE RKLHGTLPKL NFGMLRKMG.|
|Storage||-20°C; 1 mg/ml sterile filtered solution containing 10 mM sodium citrate buffer, pH 3.5 and 10 % glycerol.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
CTACK is a chemotactic factor that attracts skin-associated memory T-lymphocytes. CTACK is involved in mediating homing of lymphocytes to cutaneous sites. CTACK Binds to CCR10. CTACK human recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 89 amino acids (25-112 a.a.) and having a molecular mass of 10.3 kDa. CTACK protein is purified by standard chromatography.
Ishikawa-Mochizuki I.,et al.FEBS Lett. 460:544-548(1999).
Morales J.,et al.Proc. Natl. Acad. Sci. U.S.A. 96:14470-14475(1999).
Zaballos A.,et al.Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
Homey B.,et al.J. Immunol. 164:3465-3470(2000).
Jansma A.L.,et al.J. Biol. Chem. 285:14424-14437(2010).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.